EquitAI LogoEquitAI
$1149.36
-0.88%
LLY

LLY

Eli Lilly and Company

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
10/10
Growth
9/10
Strength
5/10
Dividend
3/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Moderate
Earnings
Growth
Dividend Yield
0.60%
Market Cap
$1.02T
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Eli Lilly is a global pharmaceutical leader that researches, develops, and sells medicines across diabetes, oncology, immunology, and neuroscience. The company is best known for its innovative biologic therapies and market-leading weight-loss treatments. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...